Legato Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History
Legato Capital Management LLC
- $718 Million
- Q4 2024
A detailed history of Legato Capital Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 27,434 shares of SUPN stock, worth $900,109. This represents 0.14% of its overall portfolio holdings.
Number of Shares
27,434
Previous 21,472
27.77%
Holding current value
$900,109
Previous $669,000
48.28%
% of portfolio
0.14%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.6MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$341 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$202 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$159 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$94.4 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$86.3 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.76B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...